| Nephrotic Syndrome
Flexbumin 25% vs Furoscix
Side-by-side clinical, coverage, and cost comparison for nephrotic syndrome.Deep comparison between: Flexbumin vs Furoscix with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsFuroscix has a higher rate of injection site reactions vs Flexbumin based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Furoscix but not Flexbumin, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Flexbumin
Furoscix
At A Glance
IV infusion
Human albumin / plasma volume expander
SC injection
Loop diuretic
Indications
- Hypoalbuminemia
- Respiratory Distress Syndrome, Adult
- Nephrotic Syndrome
- Erythroblastosis, Fetal
- Edema
- Chronic heart failure
- Chronic Kidney Diseases
- Nephrotic Syndrome
Dosing
Hypovolemic Shock Infants and young children: 2.5 to 5 mL per kg body weight IV; older children and adults: initial dose 100 to 200 mL IV, repeated after 15 to 30 minutes if response is inadequate. Do not exceed 1 mL/min in patients with normal blood volume.
Hypoalbuminemia Calculate body albumin compartment to be 80 to 100 mL per kg body weight; do not exceed a daily dose of 2 g of albumin per kg of body weight, administered IV.
Burns Dose determined by patient's condition and response to treatment after the first 24 hours, administered IV.
Erythroblastosis, Fetal 1 g per kilogram body weight IV prior to or during exchange transfusion.
Edema, Chronic heart failure, Chronic Kidney Diseases, Nephrotic Syndrome 30 mg subcutaneously over the first hour followed by 12.5 mg per hour for the subsequent 4 hours (total 80 mg) via On-body Infusor applied to the abdomen; not for chronic use, replace with oral diuretics as soon as practical.
Contraindications
- History of hypersensitivity reaction to albumin preparations or to any excipient (N-acetyltryptophan and sodium caprylate)
- Severe anemia or cardiac failure with normal or increased intravascular volume
- Anuria
- History of hypersensitivity to furosemide, any component of the FUROSCIX formulation, or medical adhesives
Adverse Reactions
Serious Hypersensitivity reaction, anaphylactic reaction, pulmonary edema
Postmarketing Anaphylactic shock, anaphylactic reaction, hypersensitivity/allergic reactions, headache, dysgeusia, myocardial infarction, atrial fibrillation, tachycardia, hypotension, flushing, pulmonary edema, dyspnea, vomiting, nausea, urticaria, rash, pruritus, pyrexia, chills
Serious fluid, electrolyte, and metabolic abnormalities, ototoxicity, anaphylactic or anaphylactoid reactions, aplastic anemia, toxic epidermal necrolysis, Stevens-Johnson syndrome, interstitial nephritis, necrotizing angiitis
Other reported pancreatitis, jaundice, nausea, vomiting, tinnitus, hearing loss, vertigo, dizziness, headache, thrombocytopenia, agranulocytosis, leukopenia, rash, erythema multiforme, orthostatic hypotension, injection site erythema and pain, muscle spasm, restlessness
Pharmacology
Human albumin accounts for 70 to 80% of the colloid osmotic pressure of normal plasma and serves as a transport protein; administered as a 25% IV solution, it draws approximately 3.5 times its volume of additional fluid into the circulation within 15 minutes, expanding blood volume.
Furosemide is a loop diuretic that primarily inhibits sodium and chloride reabsorption in the proximal and distal tubules and the loop of Henle, producing high-degree diuresis independent of carbonic anhydrase inhibition or aldosterone.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Flexbumin
- Covered on 5 commercial plans
- PA (6/12) · Step Therapy (0/12) · Qty limit (0/12)
Furoscix
- Covered on 5 commercial plans
- PA (10/12) · Step Therapy (5/12) · Qty limit (9/12)
UnitedHealthcare
Flexbumin
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Furoscix
- Covered on 4 commercial plans
- PA (5/8) · Step Therapy (4/8) · Qty limit (4/8)
Humana
Flexbumin
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (0/3) · Qty limit (0/3)
Furoscix
- Covered on 0 commercial plans
- PA (2/3) · Step Therapy (2/3) · Qty limit (0/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Flexbumin.
No savings programs available for Furoscix.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
FlexbuminView full Flexbumin profile
FuroscixView full Furoscix profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.